Replies to post #1081 on Bristol Myers Squibb (BMY)

[DewDiligence]

Camzyos sNDA for prevention of SRT* in patients with symptomatic obstructive HCM has 6/16/23 PDUFA date:

https://finance.yahoo.com/news/u-food-drug-administration-fda-105900322.html

*Septal Reduction Therapy, a surgical intervention to correct a structural heart defect.